Yahoo
OTC Markets OTCQX - Delayed Quote USD

TerrAscend Corp. (TSNDF)

0.4640 -0.0120 (-2.52%)
At close: November 6 at 4:00:00 PM EST
Chart Range Bar
Loading chart for TSNDF
  • Previous Close 0.4760
  • Open 0.4758
  • Bid 0.4641 x 1310000
  • Ask 0.4739 x 250000
  • Day's Range 0.4638 - 0.4800
  • 52 Week Range 0.3500 - 1.4500
  • Volume 174,012
  • Avg. Volume 265,043
  • Market Cap (intraday) 172.918M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -0.1100
  • Earnings Date Nov 5, 2026
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est 1.50
  • Moby Rating Neutral

TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States. The company manufactures vaporizables, concentrates, topicals, flowers, tinctures, and edibles. It offers its products under the brand name Kind Tree Cannabis, Legend, Valhalla Confections, State Flower Cannabis, Ilera Healthcare, Wana, and Cookies. The company also operates retail dispensaries under the Apothecarium brand name. It serves medical patients and adult-use consumers in North America. The company was incorporated in 2017 and is headquartered in Mississauga, Canada.

www.terrascend.com

828

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/6/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

TSNDF
36.09%
S&P/TSX Composite index (^GSPTSE)
12.31%

1-Year Return

TSNDF
32.16%
S&P/TSX Composite index (^GSPTSE)
18.89%

3-Year Return

TSNDF
71.09%
S&P/TSX Composite index (^GSPTSE)
80.53%

5-Year Return

TSNDF
91.93%
S&P/TSX Composite index (^GSPTSE)
66.80%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY26
Revenue 68.21M
Earnings -6.6M
Profit Margin -9.67%

Q4

FY25

Q1

FY26

Q2

FY26

Q3

FY26

0
20M
40M
60M
-10.0%
-5.0%
0.0%

Analyst Insights

View More

Analyst Price Targets

1.50
1.50 Average
0.4640 Current
1.50 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 3/17/2023
Analyst Needham
Rating Action Reiterates
Rating Buy
Price Action Announces
Price Target 1.75

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    -0.1100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: